About
Aims and scope
Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future by leading authorities.
Gut is the flagship of BMJ’s gastroenterology portfolio and has two companion journals, Frontline Gastroenterology for education and practice-focused papers and BMJ Open Gastroenterology for open access original research.
For information about Gut Editor-in-Chief Professor Emad El-Omar and his editorial team, please refer to the Editorial Board page.
Plan S compliance
Gut is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and  Plan S compliance on our Author Hub.
Journal information
| Ownership | Gut is co-owned by the British Society of Gastroenterology and BMJ |
|---|---|
| Publication Model | Subscription; with hybrid open access option |
| Frequency | Monthly |
| Launch date | 1960 |
| Digital Archives | Portico, LOCKSS |
| Indexed by | Web of Science Core Collection: Science Citation Index, Science Citation Index Extended; BIOSIS Preview, Current Contents: Clinical Medicine, Life Sciences; MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar |
| Impact Factor | 19.819 (JCR 2019), ranked 3/88 in Gastroenterology & Hepatology |
| Peer Review Model | Single blind; the names of reviewers are hidden from the author |
| Print ISSN | 0017-5749 |
| Online ISSN | 1468-3288 |
Journal Statistics (2020)
Acceptance rate: 13%
Speed
Days to first decision: 9 days
Days from acceptance to publication: 16 days
Impact
Impact factor (JCR): 19.819
Rank – Gastroenterology & Hepatology (JCR): 3/88
Scimago Journal rank (SJR): 7.76
Eigenfactor: 0.07141
Citescore: 32.2
Reach
2020 total content accesses: 2.07m
2020 total Altmetric mentions: 15,120
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
Contact information
For all contact information please refer to the Contact Us page.
For authors
Please refer to the Instructions for Authors.
Subscriptions
To advertise
Rights and permissions
Affiliations
Members of the British Society of Gastroenterology receive Frontline Gastroenterology as a benefit of membership; members should login to the British Society of Gastroenterology website to access the journal.
BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve reliability and value of medical research literature by promoting transparent and accurate reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.